FITCI begins transition to new facility, offers community tours Rounding into phase 1 completion of the area’s newest entrepreneurial community space at the EDGE at 321, FITCI achieved move-in approval this month. As part of the transition, startup leaders & potential resource partners can get an exclusive preview. The facility offers state-of-the-art private & shared … Read more
Theradaptive
FITCI Grad builds upon an unprecedented three Breakthrough Medical Device designations by the FDA Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department of Defense (DOD) Clinical Trial Award of up to $7.4M with options, subject to FDA approval to begin phase I/II clinical studies. Awarded … Read more
FREDERICK, Md., March 1, 2023 /PRNewswire/ — Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology & Therapeutic Development Award (TTDA) of $4 million from the U.S. Department of Defense (DOD) awarded through the Peer Reviewed Medical Research Program (PRMRP) of the Congressionally Directed Medical Research Programs (CDMRP). The contract … Read more
